Ajax-Loading

HealthEquity Inc - Price To Sales Ratio

HealthEquity Inc's Fiscal Year is From February To January.

The item "Price-To-Sales-Ratio" stands at 6.25 as of 10/31/2025.

As of the end of HealthEquity Inc's third quarter, the item "Price To Sales Ratio" stands at 6.25. This represents a decrease of -10.76 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -6.61 percent compared to the value the year prior.
The 1 year change in percent is -6.61.

The Serie's long term average value is 6.50. It's latest available value, on 10/31/2025, is 3.92 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 04/30/2023, to it's latest available value, on 10/31/2025, is +20.51%.
The Serie's change in percent from it's maximum value, on 01/31/2025, to it's latest available value, on 10/31/2025, is -23.31%.

Price To Sales Ratio for Related Companies:

LogoNameMarket Cap (USD)
LogoUnitedHealth Group Incorporated - Price To Sales Ratio299,751,047,168.00
LogoElevance Health Inc - Price To Sales Ratio74,477,723,648.00
LogoHumana Inc - Price To Sales Ratio31,012,411,392.00
LogoCentene Corp - Price To Sales Ratio18,844,801,024.00
LogoMolina Healthcare Inc - Price To Sales Ratio8,230,812,160.00